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Abstract 
According to our hypothesis, one of the mechanisms in the development and 
progression of cardiovascular diseases may be metabolic changes that are inadequate with the 
functional responses of adaptation, indicating the disruption of the functional and metabolic 
continuum (FMC). 
We suggested to study the daily rate of change in metabolism and hormonal regulation 
(morning vs. evening) in the saliva to diagnose the FMC disorders. In order to detect the FMC 
changes in patients with diabetes mellitus (DM2) complicated by arterial hypertension (AH), 
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we studied the parameters of FMC and endocrine regulation in the saliva in the morning and 
in the evening as compared to patients with diabetes mellitus. 
Previously, we have shown that in compensated DM2, there are changes in the energy 
metabolism, induced by hormonal regulation. These changes can be controlled with daily 
saliva monitoring. 
The study of the daily rhythm of in the saliva parameters makes it possible to 
conclude that in DM2, and especially in its progress, as evidenced by the accession of 
hypertension, there are disorders of FMC. One of its consequences is the development of 
oxidative stress, which is considered as one of the leading secondary mechanisms in the 
pathogenesis of DM2. 
Key words: oxidative stress, metabolism, saliva, daily rhythms, diabetes mellitus, 
arterial hypertension. 
 
In the XXI century, the steady increase in the prevalence of type 2 diabetes mellitus 
(DM2), as well as the frequency of its serious consequences, cause great concern to the world 
medical community. It is important that at the moment of diagnosis of DM2, the prevalence 
of complications that lead to a decrease in the quality of life, early disability and death is 
already high enough: 50% of patients already have coronary artery disease, 20% suffer from 
retinopathy and 20% have microalbuminuria. As is known, cardiovascular disease (CVD) is 
the main cause of death in 52% of diabetic patients [1]. 
In DM, CVD occurs 2-5 times more often than in people without this pathology. At 
the same time, the risk of developing conditions such as coronary heart disease (CHD), 
myocardial infarction (MI), arterial hypertension (AH), and acute cerebrovascular disease 
(ACVD) increases. Thus, 69% of patients with diabetes have dyslipidemia, 80% − 
hypertension, 50-75% − diastolic dysfunction, 12-22% − chronic heart failure (CHF) [1]. 
AH is a risk factor for the progression and formation of cardiovascular complications 
due to the development of pathological mechanisms, associated with damage and endothelial 
dysfunction of vessels, formation of insulin resistance (IR), activation of proinflammatory 
reactions, and disorders of the coagulation cascade, which leads to the prothrombotic state 
that is the basis of pathological processes responsible for the progression of atherosclerosis 
and increased cardiovascular risk [2, 3, 4]. The situation is complicated by the fact that among 
patients with hypertension, 50-75% have concomitant obesity. Association of these 
pathological states is a “vicious circle” wherein each component is interdependent relative to 
another, which contributes to the progression of these diseases [2, 5]. 
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Numerous research works of recent years indicate the association of diseases such as 
atherosclerosis, coronary heart disease, hypertension and diabetes mellitus, with deterioration 
of endothelium dependent vasodilation, mediated by decreased endothelial production or 
bioavailability of nitric oxide (NO). Consequently, the issue of oxidative stress also has a 
definite contribution to the development of CVD. In oxidative stress, there is an increased 
formation of free radicals and a decrease in antioxidant activity, which disturbs the balance of 
oxidative-reducing reactions and leads to serious changes in cellular function, with 
subsequent damage to the cell structure. With the participation of free radicals, peroxide 
oxidation of lipids also increases, resulting in the imbalance between the production of 
vasoconstrictor, prothrombotic and proliferative factors, on the one hand, and vasodilating, 
angioprotective and antiproliferative factors, on the other hand. Thus, all this can play an 
important role in reducing the coronary reserve in patients with AH with intact coronary 
arteries [1]. 
Comorbidity of AH and DM2 is a serious problem due to an earlier development of 
lesion to target organs and subsequent cardiovascular catastrophes [6]. 
Hyperglycemia is a major metabolic symptom of DM2, but insufficiency of insulin 
secretion begins long before the diagnosis is made – even at the pre-diabetic glycemic level. 
The likelihood of the development of fatal and non-fatal cardiovascular complications 
increases significantly not only in apparent disease, but also at the stage of pre-diabetes [7]. 
Already at the stage of glucose tolerance disturbance (GTD), the incidence of lesion to 
coronary and cerebral arteries with atherosclerosis is significantly higher than in normal 
glycemia. IR is a key link in the pathogenesis of DM2, atherosclerosis, hypertension and other 
diseases. IR is an independent risk factor for the development of dyslipidemia, systemic 
inflammation and oxidative stress [8]. 
The published results of clinical and experimental studies indicate that IR causes 
disruption of physiological mechanisms of vasodilatation. The effect of insulin on the 
vascular wall endothelium is mediated by its own receptors and is realized through a multi-
stage signaling system associated with an increase in the synthesis of nitric oxide (NO). In 
patients with hypertension and concomitant DM2, induced NO endothelium-dependent 
vasodilation is significantly reduced under the conditions of IR. It is believed that as a result 
of the activity of the cascade of proinflammatory cytokines, fat accumulation in adipocytes, 
liver, muscle, β-cells of the pancreas is observed simultaneously with increased lipolysis and 
the development of IR adipocytes [9]. The study on stratification of risk in patients with 
hypertension and diabetes mellitus conducted in Ukraine showed that almost half of patients 
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with DM2 and uncontrolled AH have a very high 4-year risk of cardiovascular complications 
characterized by high blood pressure and the presence of concomitant pathological changes. 
AH and DM2 are the components of metabolic syndrome (MS), and therefore they often 
occur against the background of obesity [9]. Data from epidemiological studies indicate that 
overwhelming majority of patients with diabetes mellitus are overweight or obese. Thus, in 
case of degree I obesity, the risk of diabetes mellitus increases by 2 times, degree II – 5 times, 
degree III – more than 10 times [10]. 
It has been established that the pathogenetic mechanisms, which predetermine the 
development of hypertension, IR and DM2, largely overlap and lead to disease progression 
and development of complications. In patients with hypertension and DM2, concomitant 
obesity is a factor in the progression of metabolic disorders, IR, activation of markers of 
immune inflammation and atherogenesis. 
In its turn, visceral obesity contributes to the imbalance of adipocytokines production, 
which leads to a chain of pathophysiological disorders in the body. The imbalance of 
adipocytokines aggravates the course of DM2 and contributes to a worsening of carbohydrate 
metabolism. Thus, an integrated approach to the study of genetic predictors in the formation 
of combined AH and DM type 2, and directly IR, can help to select a more accurate 
therapeutic tactics for patients with AH and DM 2 [6]. 
Recently, much attention has been given to chronotherapy to increase the 
effectiveness of antihypertensive treatment, to normalize the daily profile of blood pressure in 
patients with night-time AP increase (“night-peakers”) or inadequate decrease (“non-
dippers”). The reduction in the incidence of cardiovascular events and mortality for five years 
during the administration of hypotensive drugs before going to sleep [11, 31] has been shown, 
emphasizing the presence of vegetative regulation of blood pressure in diabetic patients with a 
lack of its adequate reduction in sleep [11]. 
According to our hypothesis, one of the mechanisms in the development and 
progression of cardiovascular diseases may be metabolic changes that are inadequate with the 
functional responses of adaptation, indicating a disruption of the functional and metabolic 
continuum (FMC) [12]. 
We suggested to study the daily rate of change in metabolism and hormonal regulation 
(morning vs. evening) in the saliva to diagnose the FMC disorders [13,14]. In order to detect 
the FMC changes in patients with diabetes mellitus (DM2) complicated by arterial 
hypertension (AH), we studied the parameters of FMC and endocrine regulation in the saliva 
in the morning and in the evening as compared to patients with diabetes mellitus. 
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The aim of the research 
The purpose of this research was to examine the daily rhythm of FMC in patients 
suffering from AH against the background of DM2 according to the study of saliva. 
Materials and methods of the research 
The object of the research embraced unstimulated oral fluid (mixed saliva), which was 
collected in the morning, on an empty stomach, after careful hygienic measures in the oral 
cavity, by spitting in a sterile test tube. Subsequently, the oral fluid in test tubes was 
centrifuged for 10 minutes at 2000 rpm, and the sediment portion of the fluid was used for 
biochemical studies. 
ADMA concentration was determined using liquid chromatograph LC 5000 (INGOS, 
Czech Republic), wavelength 340 nm, in isocratic mode. For solid-phase extraction 
(purification and concentration), Abselut Nexus (Varian) cartridges were used [15]. 
The activity of lipid peroxidation processes was evaluated by the concentration of 
TBC-active products. [16] 
SOD activity was determined by spectrophotometric method of V.A. Kostiuk, 
A.N. Potapov and Zh.V. Kovalev, which is based on quercetin oxidation [17]. 
Catalase activity was determined by spectrophotometric method (according to S. 
Chevari et al.) [18]. 
The content of potassium, sodium, calcium, magnesium, total lipids, triglycerides and 
cholesterol was determined by spectrophotometric methods using a set of reagents of “Filisit 
– Diagnostika” (Ukraine, Dnipro). 
The content of zinc and copper was determined using a set of reagents of DAC-
Spectro Med S.R.L (Moldova). 
The content of mucin in saliva was determined by spectrophotometric method 
(according to E.I. Ilyinykh) [19]. 
The content of lysozyme in saliva was determined using the Micrococus Lysodeicticus 
culture test, strain N2665 (by the degree of emulsion lightening) [20]. 
Results and discussion 
The differences between the two groups of independent variables were evaluated by 







Biochemical parameters of saliva of patients with DM-2 (31 people) and DM-2 + 
hypertension (AH) (9 people) in the morning (8:00). (Me [25- percentile, 75- percentile]). 
Indicator DM-2 DM-2+AH Reliability  
ADMA, μmol/l 0.071 [0.063. 0.081] 0. 141 [0.135. 0.1148] р = 0.0028 
Catalase 
mmol/sec • g protein 
14.45 [13.96. 15.68] 12.22 [11.96. 13.05] р = 0.0307 
SOD, unit/g protein 1.23 [1.11.  1.27] 1.34 [1.17. 1.39] р = 0.0411 
Lysozyme, μmol/l 0.187 [0.179; 0.191] 0.164 [0.159; 0.171] р = 0.0408 
Magnesium, mmol/l 0.345[ 0.323. 0.362] 0.264 [0.19. 0.0334] р = 0.0377 
Sodium, mmol/l 7.851 [7.562; 8.056] 7.948 [7.669; 8.109] р = 0.0492 
Copper, μmol/l 3.722 [3.453; 3.834] 3.653 [3.411. 3.782] р = 0.0527 
Calcium, mmol/l 1.862 [1.772; 1.902] 1.724 [1.684; 1.786] р = 0.0477 
Protein, g/l 2.611 [ 2.45; 2.79] 2.309 [ 2.279; 2.314] р = 0.0355 
Lipids, g/l 0.625 [0.611; 0.636] 0.637 [0.619; 0.644] р = 0.517 
Cholesterol, mmol/l 0.158 [0.146; 0.169] 0.246 [0.238; 0.258] р =0.0123 
Mucin, g/l 2.08 [1.85;  2.12] 1.79 [1.71;  1.92] р = 0.0477 
Urea, mmol/l 1.28 [ 1.12;  1.34] 1.35  [1.21; 1.38] р = 0.0614 
Uric acid, mmol/l 0.079 [0.071; 0.084] 0.075 [ 0.067; 0.082] р = 0.0685 
Glucose, mmol/l 0.082 [0.071; 0.087] 0.088 [ 0.073; 0.092] р = 0.0712 
Lactic acid, mmol/l 0.56 [ 0.51: 0.63] 0.67 [ 0.59; 0.74] р = 0.0469 
Cortisol, nmol/l 116.52 [107.18;122.05] 112.65 [105.79;120.03] Р = 0.0521 
Adrenalin, nmol/l 1.67 [1.47; 1.79] 2.09 [1.88; 2.21] р = 0.0417 
 
The sequence of intracellular oxidative-reduction reactions in the body is a finely 
controlled process. Active forms of oxygen (AFO) are involved in important biological 
reactions, but their excessive production and accumulation can lead to oxidative stress. Thus, 
IR is accompanied by a disruption of the AFO metabolism, which leads to the development of 
oxidative stress. There is evidence that oxidative stress is one of the causes of muscle 
disorders that contribute to the formation of IR. The importance of AFO and activation of 
LPO in the pathogenesis of DM2 complications is undeniable. The leading role of 
hyperglycemia in initiating and potentiating the generation of AFO has been established. 
There is strong evidence that damage to the β-cells of the Langerhans islets and, as a 
consequence, insufficiency of insulin secretion, may be due to the activation of oxidative 
stress mediated by hyperglycemia. The peculiarity of β-cells is low production of antioxidant 
enzymes, which results in the accumulation of AFO [21]. 
The data shown in Table 1 indicate that there are significant differences already in the 
morning between patients with diabetes and diabetes complicated by AH. One the main of 
these differences is the concentration of ADMA twice as large in the group of patients with 
DM and AH, which is accompanied by a decrease in the activity of SOD. That is, there are 
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signs of development of oxidative stress in patients, probably due to the reduction of 
antioxidant defense. 
Table 2.  
Biochemical parameters of saliva of patients with DM-2 (31 people) and DM-2 + 
hypertension (AH) (9 people) in the evening hours (20:00). (Me [25- percentile, 75- 
percentile]). 
Indicator DM-2 DM-2+AH Reliability  
ADMA, μmol/l 0.112 [0.105; 0.121] 0.155 [0.141; 0.166] р = 0.0337 
Catalase 
mmol/sec•g protein 
11.27 [10.79; 12.18] 14.62 [13.42; 15.71] р = 0.0412 
SOD, unit/g protein 0.81 [ 0.74; 0.92] 1.37 [1.21; 1.45] р = 0.0365 
Lysozyme, μmol/l 0.164 [0.155; 0.173] 0.137 [0.129; 0.144] Р = 0.0405 
Magnesium, mmol/l 0.31 [0.27; 0.35] 0.19 [0.16; 0.24] р = 0.0392 
Sodium, mmol/l 7.65 [7.01; 8.32] 7.86 [7.43; 8.55] р = 0.0658 
Copper, μmol/l 3.88 [3.52; 4.21] 3.54 [3.21; 3.86] р = 0.0483 
Calcium, mmol/l 1.73 [1.57; 1.86] 1.48 [1.33; 1.60] р = 0.0489 
Protein, g/l 2.69 [2.41; 2.91] 2.18 [2.09; 2.31] р = 0.0 465 
Lipids, g/l 0.73 [ 0.64; 0.81] 0.69 [0.64; 0.75] р = 0.579 
Cholesterol, mmol/l 0.25 [0.22; 0.28] 0.30 [0.26; 0.34] р = 0.0605 
Mucin, g/l 1.59 [1.48; 1.68] 1.78 [1.61; 1.90] р =  0.0466 
Urea, mmol/l 1.39 [1.26; 1.52] 1.47 [1.32;  1.62] р = 0.0552 
Uric acid, mmol/l 0.085 [0.079; 0.092] 0.105 [0.094; 0.114] р = 0.0492 
Glucose, mmol/l 0.097 [0.089; 0.104] 0.092 [0.083; 0.101] р = 0.0702 
Lactic acid, mmol/l 0.66 [0.62; 0.71] 0.72 [0.65; 0.78] р = 0.0511 
Cortisol, nmol/l 127.69 [116.32; 140.13] 126.45 [117.14; 138.32] р = 0.0714 
Adrenalin, nmol/l 1.25 [1.13;  1.37] 1.79  [1.61; 1.92] р = 0.0447 
 
It should be noted that disturbances are observed in metabolic rate – the level of 
cholesterol and lactic acid increased. Attention is drawn to the fact that the level of adrenalin 
was higher in diabetic patients with AH. Indicators in the saliva in the evening (Table 2) 
according to the main parameters had the same changes. In both groups of patients, the 
concentration of ADMA increased even more, especially in DM combined with AH, whereas 
the level of adrenalin, although decreasing toward the evening, but was certainly higher in the 
second group.  
Thus, if we compare the indicators in the saliva collected in the evening, then we can 
acknowledge the disruptions, which testify to the presence of oxidative stress and changes in 
FMC in patients, which increase as compared with the healthy ones in patients with diabetes 
(Fig. 1), and concomitant AH increases the degree of these disorders (Fig. 4). 
Figure 2 shows that in patients with diabetes, there are higher concentration of the 
salivary cortisol, and the accession of AH is accompanied by an increase in the level of 
 590 
adrenalin, indicating the possible role of activation of the sympathetic and adrenal system in 





Thus, the study of the circadian rhythm of the parameters in the saliva makes it 
possible to conclude that in the case of diabetes, and especially with its progress, as evidenced 
by the accession of AH, complex disruptions of FMС occur. One of its consequences is the 
development of oxidative stress, which is considered as one of the leading secondary 
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